Custom Synthetic Intermediates
374790-98-4
Boiling point: 326.4±52.0 °C(Predicted)
Density: 2.01±0.1 g/cm3(Predicted)
Storage temp.: under inert gas (nitrogen or Argon) at 2–8 °C
Availability: | |
---|---|
Product Description
We are a pharmaceutical intermediate manufacturer of 2-Fluoro-4-Iodophenylboronic Acid.
Its CAS No. is 374790-98-4
Our pharmaceutical intermediates can be used in a variety of APIs.
Product Category | Custom Synthetic Intermediates |
CAS NO | 374790-98-4 |
Product Specifications | Boiling point: 326.4±52.0 °C(Predicted) Density: 2.01±0.1 g/cm3(Predicted) Storage temp.: under inert gas (nitrogen or Argon) at 2–8 °C |
Office Environment
Laboratory
Workshop/Warehouse
Certificate
2-Fluoro-4-Iodophenylboronic Acid is produced by EASTFINE , and we are in charge of overseas selling . Not just trading compamy .
China,America,Brazil,England,Russia,Poland,India,Pakistan,NewZealand,Korea,Australia,Dubai,Turkey,Indonesia,UAE.
yes , you can have 1 2-Fluoro-4-Iodophenylboronic Acid sample for starting the business , but it is not free
please contact sale team for detail .
2-Fluoro-4-iodophenylboronic acid (CAS 374790-98-4) is a halogenated organoboron compound with molecular formula C₆H₅BFIO₂. This off-white to beige crystalline solid features a reactive boronic acid group adjacent to both fluorine and iodine substituents on the aromatic ring, making it particularly valuable for transition metal-catalyzed cross-coupling reactions in pharmaceutical synthesis.
The compound typically appears as an off-white to light beige powder with a molecular weight of 265.82 g/mol. It has a melting point range of 180-185°C (with decomposition) and shows moderate solubility in polar aprotic solvents like DMF and THF, though limited solubility in water and non-polar solvents. The material is air-stable but should be protected from prolonged light exposure.
For optimal stability, store in amber glass containers with desiccants under inert atmosphere (nitrogen or argon) at 2-8°C. The boronic acid group is moisture-sensitive, so containers should be tightly sealed and protected from humidity. Under these conditions, the material maintains excellent stability for at least 18 months. Keep away from strong oxidizing agents.
This compound serves as a versatile building block in medicinal chemistry, especially for constructing fluorinated and iodinated biaryl structures through Suzuki-Miyaura couplings. The iodine substituent enables additional transformations via halogen exchange reactions, while the fluorine enhances metabolic stability in drug candidates. It's particularly valuable in developing kinase inhibitors and PET imaging agents.
The material may cause mild skin and eye irritation. Appropriate PPE including nitrile gloves and safety goggles should be worn during handling. Avoid inhalation of dust and work in a well-ventilated area. While not highly toxic, ingestion should be avoided. In case of exposure, flush affected areas with water. The compound is stable under normal laboratory conditions.
Quality control includes HPLC analysis (typically ≥95% purity), melting point determination, and spectroscopic characterization. ⊃1;H NMR confirms the aromatic proton pattern, while ⊃1;⊃1;B NMR verifies the boronic acid functionality. Mass spectrometry provides molecular weight confirmation. Iodine content may be verified by elemental analysis.
The unique combination of substituents creates multiple advantages: the iodine enables versatile cross-coupling and conversion to other functionalities, the fluorine enhances electronic properties and metabolic stability, while the boronic acid facilitates efficient biaryl formation. This trifunctional nature makes it exceptionally useful for constructing complex pharmaceutical intermediates.
This specialty reagent is commercially available through fine chemical suppliers in quantities ranging from milligrams to kilograms. Many suppliers provide certificates of analysis with each batch and can accommodate custom synthesis requests. Technical support is typically available for specific application development questions.